The city of Buenos Aires on Thursday enabled the registration of children from 3 to 11 years old without risk factors to be immunized against the new coronavirus, a process that has already begun in other jurisdictions in Argentina.
Fernán Quirós, Minister of Health of the capital, announced at a press conference that registration was opened on the website enabled to receive the Sinopharm vaccine after having completed the immunization of children with comorbidities of that age group.
According to the official, the vaccination of children without health problems will begin in a few more days, when the immunization of the last adolescents between 12 and 17 years old who should receive the first dose of the vaccine is completed. Pfizer.
“We will begin to invite in turns, always in order of age; first to those of 11 years, then to those of 10 and so on,” said Quirós.
In recent days, doctors warned about the need to advance with the immunization of minors in the capital, as has been done in the province of Buenos Aires, the most populated in the country, and other Argentine jurisdictions since October 12.
Oscar Trotta, one of the members of the board of directors of the Garrahan Hospital -the most recognized pediatric center in the country- said this week that the vaccination of children without comorbidities should not delay, noting that in other countries the contagious Delta strain “presents a focus concentration in smaller populations “.
The Argentine Minister of Health, Carla Vizzotti, said two days ago “that 10% of the target population” between 3 and 11 years of age was reached in different provinces of the country. Since the pandemic hit Argentina, more than 5.2 million people have been infected and more than 115,700 have died.
Some 32 million people have received one dose of some vaccine and about 24.9 million the two doses out of a population of about 45 million.
Epidemiological values have improved notably in the last 20 weeks thanks to the advance of vaccination, but infectologists have warned that the proportion of the Delta variant is increasing in some urban agglomerates.